Perrigo Company PLC
PRGO
Real-time BATS EXCHANGE - 12/10 06:09:12 pm
58.155USD
-2.84%
Prev.59.9300
Open59.4900
High59.8100
Low57.7000
Volume302 437
Financials
Sales 2018 4 717 M
EBIT 2018 872 M
R. net 2018 132 M
Debt 2018 2 720 M
Rend. 2018 1,28%
P/E ratio 2018 36,69
P/E ratio 2019 21,40
EV / Sales 2018 2,30x
EV / Sales 2019 2,21x
Capitalization 8 142 M
Company
Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences....
Sector :
Pharmaceuticals - NEC
Calendar :
2019-02-14 Earnings Release
Trading Rating :
Investor Rating :
Latest news
02:54pPERRIGO : Announces the Launch of an AB Rated Generic Version of Topicort® Topical Spray 0.25%
PR
12/05SOL GEL TECHNOLOGIES : Announces Sixth Agreement for a Generic Product Candidate with Perrigo
AQ
12/04PERRIGO : Sol-Gel Technologies Announces Sixth Agreement for a Generic Product Candidate with Perrigo
AQ
11/29PERRIGO : Announces Patent Litigation Settlement for the Generic Version of Sernivo Spray, 0.05%
AQ
11/29PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/28PERRIGO : Announces Patent Litigation Settlement For The Generic Version Of Sernivo® Spray, 0.05%
PR
11/27PERRIGO : Launches Its AB Rated Generic Version of Solaraze® Gel 3%
PR
11/27PERRIGO : Announces Tentative FDA Approval for the First to File Generic Version of Ultravate Lotion 0.05%
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance68,068,076,5
Spread/Res.-14%-14%-24%
Spread/Supp.7,3%7,3%15%
Support54,354,350,7